Literature DB >> 2987695

An erythema infectiosum-like illness caused by human parvovirus infection.

F A Plummer, G W Hammond, K Forward, L Sekla, L M Thompson, S E Jones, I M Kidd, M J Anderson.   

Abstract

In the spring of 1980, an epidemic of an illness that resembled erythema infectiosum occurred in Manitoba, Canada. We initiated prospective epidemiologic, clinical, and microbiologic studies of this illness among elementary-school children and their families. Initial microbiologic studies failed to identify the cause of the exanthem. After a similar illness associated with serologic evidence of human parvovirus infection occurred in London, stored specimens of 12 patients with exanthem were investigated for parvovirus infection. Eleven patients had parvovirus-specific IgM antibody, as did two family contacts and a teacher with nonexanthematous illnesses, and two asymptomatic family members. None of 28 children with measles or rubella had serologic evidence of recent parvovirus infection. Human parvovirus was detected by DNA hybridization and immune electron microscopy in the serum of one patient who later had a rash and in one unaffected family contact. Parvovirus DNA was also detected in the pharyngeal specimen of the teacher who was ill but did not have a rash. We conclude that human parvovirus infection can be asymptomatic or cause a variety of clinical manifestations, including nonexanthematous illness and an illness resembling erythema infectiosum.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2987695     DOI: 10.1056/NEJM198507113130203

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  30 in total

Review 1.  Pathogenesis of human parvovirus B19 in rheumatic disease.

Authors:  J R Kerr
Journal:  Ann Rheum Dis       Date:  2000-09       Impact factor: 19.103

Review 2.  Parvovirus B19 infection in human pregnancy.

Authors:  R F Lamont; J D Sobel; E Vaisbuch; J P Kusanovic; S Mazaki-Tovi; S K Kim; N Uldbjerg; R Romero
Journal:  BJOG       Date:  2010-10-13       Impact factor: 6.531

3.  Chemiluminescence dot blot hybridization assay for detection of B19 parvovirus DNA in human sera.

Authors:  M Musiani; M Zerbini; D Gibellini; G Gentilomi; S Venturoli; G Gallinella; E Ferri; S Girotti
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

4.  [Outbreak of infectious erythema at a urban health center].

Authors:  A I Revilla Grande; T Carro García; M Sánchez de Dios; M J Galán Calvo; T Nebreda Mayoral
Journal:  Aten Primaria       Date:  2000 Jul-Aug       Impact factor: 1.137

5.  Variation of erythroid and myeloid precursors in the marrow and peripheral blood of volunteer subjects infected with human parvovirus (B19).

Authors:  C G Potter; A C Potter; C S Hatton; H M Chapel; M J Anderson; J R Pattison; D A Tyrrell; P G Higgins; J S Willman; H F Parry
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

6.  Brachial plexus neuropathy associated with human parvovirus infection.

Authors:  K J Walsh; R D Armstrong; A M Turner
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-26

7.  Severe aplastic anaemia after parvovirus infection in the absence of underlying haemolytic anaemia.

Authors:  M D Hamon; A C Newland; M J Anderson
Journal:  J Clin Pathol       Date:  1988-11       Impact factor: 3.411

8.  Erythema infectiosum in a village primary school: clinical and virological studies.

Authors:  J G Tuckerman; T Brown; B J Cohen
Journal:  J R Coll Gen Pract       Date:  1986-06

9.  Prokaryotic expression of a VP1 polypeptide antigen for diagnosis by a human parvovirus B19 antibody enzyme immunoassay.

Authors:  M Söderlund; K E Brown; O Meurman; K Hedman
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

Review 10.  Electron microscopy for rapid diagnosis of infectious agents in emergent situations.

Authors:  Paul R Hazelton; Hans R Gelderblom
Journal:  Emerg Infect Dis       Date:  2003-03       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.